At last, we revealed the infiltration of Trm_gut_CD8 in colorectal cancer and demonstrated that the infiltration of Trm_gut_CD8 specifically derived from DUO and ILE benefitted the overall survival and response to immune checkpoint blockade therapy which might be utilized as prognosis markers. The gene discussed is CD8A; the disease is colorectal cancer.